Program
"Preparation, Computation and Intellectual Property"
Friday, 3rd September 2010
|
9:00 |
Developing cocrystal in pharmaceutical products Scott Childs, Renovo Research
|
|
9:30 |
Drug crystallisation in micro channel reactors Nick Bladgen, University of Bradford
|
|
10:00 |
Stress and Strain in Crystal Engineering Mark Hollingsworth, Kansas State University
|
|
10:30 |
Coffee Break |
|
11:00 |
Engineering cocrystal thermodynamic stability via micellar solubilization Nair Hornedo Rodriguez, University of Michigan
|
|
11:30 |
Crystalline Forms and Patents in the Pharmaceutical Industry Heinz-Josef Deussen, LEO Pharma
|
|
12:00 |
Targeting Right Polymorphs and Hydrates in Manufacturing of APIs Peter Karpinski, Novartis
|
|
12:30 |
Patenting solid form state inventions: myths and reality Bertrand Gellie, European Patent Office
|
|
13:00 |
Lunch
|
|
14:30 |
Polymorphism in drug development: 5HT6 agonist Walter Cabri, Sigma-Tau
|
|
15:00 |
Complementary microscopy techniques IR-Raman for the analisys of pharmaceutical polymorphs Barbara Bravo, Thermofisher
|
|
15:30 |
Exploring Molecular Recognition Through Macroscopic Properties Alessia Bacchi, University of Parma
|
|
16:00 |
Polymorphs in supercritical processes: a pharmaceutical prospect Ruggero Bettini, University of Parma
|
|
16:30 |
Coffee Break
|
|
17:00 |
First principles study of the biestability in molecular magnetic crystals Juan Novoa, University of Barcelona
|
|
17:30 |
Crystal structure prediction by example – return on experience for salts and hydrates Marcus Neumann, Avant-Garde Material Simulation
|
|
18:00 |
Hydrate - Anhydrate and Solvate - Non-solvate Equilibria Fritz Blatter, Solvias AG
|
|
18:30 |
Recent advances in structure determination: new expertise for PolyCrystalLine Lucia Maini, University of Bologna |